. Requirement for c-Myc and cyclin D1 for breast cancer cell proliferation. (a) Proliferation of MCF-7 transfected with a siRNA targeting c-Myc, cyclin D1, or with N.S. siRNA as control and incubated in presence or absence of conditioned KG-1 macrophages for 48 h with the indicated ligands and measured by CyQUANT, n = 3. Analysis was performed by two-way ANOVA with Sidak multiple comparison test (α = 0.05): * in comparison with Control N.S. siRNA in indicated treatment of each group; e.g., TNF siRNA c-Myc vs. TNF Control N.S. siRNA; Δ in comparison with respective Cntrl of each group; (b) Cyclin D1 or c-Myc gene expression in MCF-7 transfected with siRNA targeting cyclin D1, c-Myc or N.S. siRNA. MCF-7 were cultured in the presence of conditioned KG-1 macrophages for 48 h. Cells were treated as indicated for 2 h prior to be harvested and processed for qPCR. Relative mRNA expression with respect to control (N.S. siRNA) was calculated by the 2 −ΔΔCt method n = 4. Analysis as in panel a: Δ in comparison with Cntrl of each group; * in comparison with N.S.siRNA in indicated treatment of cyclin D1 or c-Myc; (c) ChiP assay of trimethylated Lys-4 on Histone-3 (Me3-H3K4) and RNA Polymerase II (Pol II) followed by qPCR analysis of the cyclin D1 promoter in MCF-7 cultured alone (left) or in the presence of conditioned KG-1 macrophages (right) for 24 h. The cultures received the indicated treatments 2 h prior to harvesting. Results are normalized to non-specific IgG Ab, n = 4. Analysis as in panel a: Δ in comparison with Cntrl of each group; * in comparison with absence of macrophages of each group; e.g., E2 (Pol II, MCF-7 + Macrophages) vs. E2 (Pol II, MCF-7). References: Cntrl: Fresh DMEM, E2: Estradiol 1 nM, TNF: TNF-α 1 ng/mL, Tam: Tamoxifen 1 µM, ICI: ICI 182,780 1 µM. Shown are the mean ± SEM from 3 independent experiments. * p < 0.05; ** p < 0.01; *** p < 0. 001; **** p < 0. 0001; Δ p < 0.05; ΔΔ p < 0.01; ΔΔΔ p < 0.001; ΔΔΔΔ p < 0.0001. Figure S3 . ChiP analyses of c-Myc promoter. ChiP assay of (a,b) ERα, and p65; (c,d) NCOR, SRC1, and CBP; (e,f) trimethylated Lys-4 on Histone-3 (Me3-H3K4), and RNA Polymerase II (Pol II) followed by qPCR of the cyclin D1 promoter in MCF-7 cultured alone (a,c,e) or in the presence of conditioned KG-1 macrophages (b,d,f) for 24 h. The cultures received the indicated treatments 2 h prior to harvesting. Results are normalized to non-specific IgG Ab, n = 4. Analysis was performed by two-way ANOVA with Sidak multiple comparison test (α = 0.05): Δ in comparison with Cntrl of each group; * in comparison with absence of macrophages in indicated treatment of each group; e.g., E2 (ERα MCF-7+ Macrophages) vs. E2 (ERα MCF-7). References: Cntrl: Fresh DMEM, E2: Estradiol 1 nM, TNF: TNF-α 1 ng/mL, Tam: Tamoxifen 1 µM, ICI: ICI 182,780 1 µM. Results are the mean ± SEM of three experiments performed. * p < 0.05; ** p < 0.01; *** p < 0. 001; **** p < 0. 0001; Δ p < 0.05; ΔΔ p < 0.01; ΔΔΔ p < 0.001; ΔΔΔΔ p < 0.0001; NSS: not statistically significant. Figure S4 . Culture medium-Cytokine analysis in MCF-7, KG-1 macrophages or co-culture of both cell lines. MCF-7, KG-1 macrophages and MCF-7-KG-1 macrophages co-cultured were treated with TNF (1 ng/mL) for 6 h and then washed. The media was collected 24 h later and analyzed for cytokine antibody protein array. Unstimulated cells were used as control. Results are the mean ± SEM of three experiments performed. * p < 0.05; ** p < 0.01; *** p < 0. 001; **** p < 0. 0001; Δ p < 0.05; ΔΔ p < 0.01; ΔΔΔ p < 0.001; ΔΔΔΔ p < 0.0001. Figure S7 . KG-1 macrophages increase the interaction between p65, STAT3, and ER proteins in MCF-7. IP of p65, STAT3, or ERα followed by Western blotting (WB) of MCF-7 cultured in the presence or the absence of conditioned KG-1 macrophages separated by a semipermeable membrane for 24 h. Cells were treated 2 h before harvesting as indicated in each lane. References: Cntrl: Fresh DMEM, E2: Estradiol 1 nM, TNF: TNF-α 1 ng/mL, IL-6: Interleukin 6 1 ng/mL, EGF: Epidermal growth factor 10 ng/mL, Tam: Tamoxifen 1 µM, MW: Molecular weight marker.
